Terms: = Leukemia AND CD74, ENSG00000019582, 972, protein 41, Ia-GAMMA, HLADG, DHLAG
119 results:
1. Identifying proteomic risk factors for cancer using prospective and exome analyses of 1463 circulating proteins and risk of 19 cancers in the UK Biobank.
Papier K; Atkins JR; Tong TYN; Gaitskell K; Desai T; Ogamba CF; Parsaeian M; Reeves GK; Mills IG; Key TJ; Smith-Byrne K; Travis RC
Nat Commun; 2024 May; 15(1):4010. PubMed ID: 38750076
[TBL] [Abstract] [Full Text] [Related]
2. Identification of cells of leukemic stem cell origin with non-canonical regenerative properties.
Hollands CG; Boyd AL; Zhao X; Reid JC; Henly C; ElRafie A; Boylan D; Broder E; Kalau O; Johnson P; Mark A; McNicol J; Xenocostas A; Berg T; Foley R; Trus M; Leber B; Garcia-Horton A; Campbell C; Bhatia M
Cell Rep Med; 2024 Apr; 5(4):101485. PubMed ID: 38582086
[TBL] [Abstract] [Full Text] [Related]
3. Non-canonical Hedgehog signaling mediates profibrotic hematopoiesis-stroma crosstalk in myeloproliferative neoplasms.
Pritchard JE; Pearce JE; Snoeren IAM; Fuchs SNR; Götz K; Peisker F; Wagner S; Benabid A; Lutterbach N; Klöker V; Nagai JS; Hannani MT; Galyga AK; Sistemich E; Banjanin B; Flosdorf N; Bindels E; Olschok K; Biaesch K; Chatain N; Bhagwat N; Dunbar A; Sarkis R; Naveiras O; Berres ML; Koschmieder S; Levine RL; Costa IG; Gleitz HFE; Kramann R; Schneider RK
Cell Rep; 2024 Jan; 43(1):113608. PubMed ID: 38117649
[TBL] [Abstract] [Full Text] [Related]
4. Analysis of cd74 Occurrence in Oncogenic Fusion proteins.
Vargas J; Pantouris G
Int J Mol Sci; 2023 Nov; 24(21):. PubMed ID: 37958963
[TBL] [Abstract] [Full Text] [Related]
5. Development and external validation of the multichannel deep learning model based on unenhanced CT for differentiating fat-poor angiomyolipoma from renal cell carcinoma: a two-center retrospective study.
Yao H; Tian L; Liu X; Li S; Chen Y; Cao J; Zhang Z; Chen Z; Feng Z; Xu Q; Zhu J; Wang Y; Guo Y; Chen W; Li C; Li P; Wang H; Luo J
J Cancer Res Clin Oncol; 2023 Nov; 149(17):15827-15838. PubMed ID: 37672075
[TBL] [Abstract] [Full Text] [Related]
6. Pesticides as a potential independent childhood leukemia risk factor and as a potential confounder for electromagnetic fields exposure.
Nguyen A; Crespi CM; Vergara X; Kheifets L
Environ Res; 2023 Dec; 238(Pt 1):116899. PubMed ID: 37598846
[TBL] [Abstract] [Full Text] [Related]
7. Consumption of aspartame and other artificial sweeteners and risk of cancer in the Spanish multicase-control study (MCC-Spain).
Palomar-Cros A; Straif K; Romaguera D; Aragonés N; Castaño-Vinyals G; Martin V; Moreno V; Gómez-Acebo I; Guevara M; Aizpurua A; Molina-Barceló A; Jiménez-Moleón JJ; Tardón A; Contreras-Llanes M; Marcos-Gragera R; Huerta JM; Pérez-Gómez B; Espinosa A; Hernández-Segura N; Obón-Santacana M; Alonso-Molero J; Burgui R; Amiano P; Pinto-Carbó M; Olmedo-Requena R; Fernández-Tardón G; Santos-Sánchez V; Fernández de Larrea-Baz N; Fernández-Villa T; Casabonne D; Dierssen-Sotos T; Ardanaz E; Dorronsoro A; Pollán M; Kogevinas M; Lassale C
Int J Cancer; 2023 Sep; 153(5):979-993. PubMed ID: 37323037
[TBL] [Abstract] [Full Text] [Related]
8. Prospective Identification of Prognostic Hot-Spot Mutant Gene Signatures for leukemia: A Computational Study Based on Integrative Analysis of TCGA and cBioPortal Data.
Zhang M; Lang X; Chen X; Lv Y
Mol Biotechnol; 2023 Nov; 65(11):1898-1912. PubMed ID: 36879146
[TBL] [Abstract] [Full Text] [Related]
9. cd74 as a regulator of transcription in normal B cells.
David K; Friedlander G; Pellegrino B; Radomir L; Lewinsky H; Leng L; Bucala R; Becker-Herman S; Shachar I
Cell Rep; 2022 Nov; 41(5):111572. PubMed ID: 36323260
[TBL] [Abstract] [Full Text] [Related]
10. Subclones of bone marrow CD34
Jia R; Ji M; Li G; Xia Y; Guo S; Li P; Sun Y; Lu F; Zhang J; Zang S; Yan S; Ye J; Xue F; Ma D; Sun T; Ji C
Cancer; 2022 Nov; 128(22):3929-3942. PubMed ID: 36197314
[TBL] [Abstract] [Full Text] [Related]
11. Identification of Immune Infiltration and Effective Immune Biomarkers in Acute Lung Injury by Bioinformatics Analysis.
Ling D; Zhang X; Wu J; Xu Q; He Z; Zhang J
Cell Transplant; 2022; 31():9636897221124485. PubMed ID: 36165281
[TBL] [Abstract] [Full Text] [Related]
12. CXCR4 and cd74 together enhance cell survival in response to macrophage migration-inhibitory factor in chronic lymphocytic leukemia.
Thavayogarajah T; Sinitski D; El Bounkari O; Torres-Garcia L; Lewinsky H; Harjung A; Chen HR; Panse J; Vankann L; Shachar I; Bernhagen J; Koschmieder S
Exp Hematol; 2022 Nov; 115():30-43. PubMed ID: 36096455
[TBL] [Abstract] [Full Text] [Related]
13. Frequent HLA-DR loss on hematopoietic stem progenitor cells in patients with cyclosporine-dependent aplastic anemia carrying HLA-DR15.
Tsuji N; Hosokawa K; Urushihara R; Tanabe M; Zaimoku Y; Katagiri T; Ozawa T; Takamatsu H; Ishiyama K; Yamazaki H; Kishi H; Ogawa S; Nakao S
Leukemia; 2022 Jun; 36(6):1666-1675. PubMed ID: 35474098
[TBL] [Abstract] [Full Text] [Related]
14. Interplay between soluble cd74 and macrophage-migration inhibitory factor drives tumor growth and influences patient survival in melanoma.
Fukuda Y; Bustos MA; Cho SN; Roszik J; Ryu S; Lopez VM; Burks JK; Lee JE; Grimm EA; Hoon DSB; Ekmekcioglu S
Cell Death Dis; 2022 Feb; 13(2):117. PubMed ID: 35121729
[TBL] [Abstract] [Full Text] [Related]
15. Association of ITPA gene polymorphisms with adverse effects of AZA/6-MP administration: a systematic review and meta-analysis.
Barba E; Kontou PI; Michalopoulos I; Bagos PG; Braliou GG
Pharmacogenomics J; 2022 Feb; 22(1):39-54. PubMed ID: 35034963
[TBL] [Abstract] [Full Text] [Related]
16. Cytarabine dose reduction in patients with low-risk acute myeloid leukemia: A report from the Children's Oncology Group.
Getz KD; Alonzo TA; Sung L; Meshinchi S; Gerbing RB; Raimondi S; Hirsch B; Loken M; Brodersen LE; Kahwash S; Choi J; Kolb EA; Gamis A; Aplenc R
Pediatr Blood Cancer; 2022 Jan; 69(1):e29313. PubMed ID: 34472213
[TBL] [Abstract] [Full Text] [Related]
17. Macrophage migration inhibitory factor in the pathogenesis of leukemia (Review).
Luo Y; Wang X; Shen J; Yao J
Int J Oncol; 2021 Aug; 59(2):. PubMed ID: 34278453
[TBL] [Abstract] [Full Text] [Related]
18. The genomic landscape of teenage and young adult T-cell acute lymphoblastic leukemia.
Mansur MB; Furness CL; Nakjang S; Enshaei A; Alpar D; Colman SM; Minto L; Irving J; Poole BV; Noronha EP; Savola S; Iqbal S; Gribben J; Pombo-de-Oliveira MS; Ford TM; Greaves MF; van Delft FW
Cancer Med; 2021 Jul; 10(14):4864-4873. PubMed ID: 34080325
[TBL] [Abstract] [Full Text] [Related]
19. The MHC-II antigen presentation machinery and B7 checkpoint ligands display distinctive patterns correlated with acute myeloid leukaemias blast cells HLA-DR expression.
Antohe I; Tanasa MP; Dăscălescu A; Dănăilă C; Titieanu A; Zlei M; Ivanov I; Sireteanu A; Cianga P
Immunobiology; 2021 Jan; 226(1):152049. PubMed ID: 33352400
[TBL] [Abstract] [Full Text] [Related]
20. The Application of
Wang L; Chen K; Xu Q
Biomed Res Int; 2020; 2020():3687134. PubMed ID: 33299868
[TBL] [Abstract] [Full Text] [Related]
[Next]
